ArticleThe Journal of clinical investigation2025
PPIL2 is a target of the JAK2/STAT5 pathway and promotes myeloproliferation via degradation of p53.
Pan Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it